Melanoma cells present high levels of HLA-A2-tyrosinase in association with instability and aberrant intracellular processing of tyrosinase

European Journal of Immunology

Volumn 42, Issue 4, 2012, Pages 842-850

  Michaeli, Yael ^a   Sinik, Keren ^a   Haus Cohen, Maya ^a   Reiter, Yoram ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Class I MHC processing and presentation; TCR like antibody; Tumor antigens; Tumor immunology; Tyrosinase

Indexed keywords

HLA A2 ANTIGEN; LEVODOPA; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MESSENGER RNA; MONOPHENOL MONOOXYGENASE;

ANTIGEN PRESENTATION; ARTICLE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTRACELLULAR MEMBRANE; MELANOMA CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIGEN PRESENTATION; CELL LINE, TUMOR; GLYCOSYLATION; HLA-A2 ANTIGEN; HUMANS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MELANOMA; MELANOSOMES; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; PEPTIDES; PROTEIN STABILITY; RNA, MESSENGER;

EID: 84860250730     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141511     Document Type: Article

References (20)

1. Schubert, U., Anton, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W. and Bennink, J. R., Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000. 404: 770-774.
2. Reits, E. A., Vos, J. C., Gromme, M. and Neefjes, J., The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 2000. 404: 774-778.
3. Esquivel, F., Yewdell, J. and Bennink, J., RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes. J. Exp. Med. 1992. 175: 163-168.
4. Mackay, L. K., Long, H. M., Brooks, J. M., Taylor, G. S., Leung, C. S., Chen, A., Wang, F. et al., T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope display. PLoS Pathog. 2009. 5: e1000699.
5. Princiotta, M. F., Finzi, D., Qian, S. B., Gibbs, J., Schuchmann, S., Buttgereit, F., Bennink, J. R. et al., Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 2003. 18: 343-354.
6. Romero, P., Cerottini, J. C. and Speiser, D. E., The human T cell response to melanoma antigens. Adv. Immunol. 2006. 92: 187-224.
7. Garcia-Borron, J. C. and Solano, F., Molecular anatomy of tyrosinase and its related proteins: beyond the histidine-bound metal catalytic center. Pigm. Cell. Res. 2002. 15: 162-173.
8. Halaban, R., Cheng, E., Zhang, Y., Moellmann, G., Hanlon, D., Michalak, M., Setaluri, V. et al., Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells. Proc .Natl. Acad. Sci. USA 1997. 94: 6210-6215.
9. Halaban, R., Patton, R. S., Cheng, E., Svedine, S., Trombetta, E. S., Wahl, M. L., Ariyan, S. et al., Abnormal acidification of melanoma cells induces tyrosinase retention in the early secretory pathway. J. Biol. Chem. 2002. 277: 14821-14828.
10. Halaban, R., Cheng, E., Svedine, S., Aron, R. and Hebert, D. N., Proper folding and endoplasmic reticulum to golgi transport of tyrosinase are induced by its substrates, DOPA and tyrosine. J. Biol. Chem. 2001. 276: 11933-11938.
11. Skipper, J. C., Hendrickson, R. C., Gulden, P. H., Brichard, V., Van, P. A., Chen, Y., Shabanowitz, J. et al., An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J. Exp. Med. 1996. 183: 527-534.
12. Michaeli, Y., Denkberg, G., Sinik, K., Lantzy, L., Chih-Sheng, C., Beauverd, C., Ziv, T., et al., Expression hierarchy of T cell epitopes from melanoma differentiation antigens: unexpected high level presentation of tyrosinase-HLA-A2 complexes revealed by peptide-specific, MHC-restricted, TCR-like antibodies. J. Immunol. 2009. 182: 6328-6341.
13. Ostankovitch, M., Robila, V. and Engelhard, V. H., Regulated folding of tyrosinase in the endoplasmic reticulum demonstrates that misfolded full-length proteins are efficient substrates for class I processing and presentation. J. Immunol. 2005. 174: 2544-2551.
14. Ostankovitch, M., Trich-Vanlith, M., Robila, V. and Engelhard, V. H., N-glycosylation enhances presentation of a MHC class I-restricted epitope from tyrosinase. J. Immunol. 2009. 182: 4830-4835.
15. + T cell activation. J. Immunol. 2008. 180: 372-382.
16. Golovina, T. N., Morrison, S. E. and Eisenlohr, L. C., The impact of misfolding versus targeted degradation on the efficiency of the MHC class I-restricted antigen processing. J. Immunol. 2005. 174: 2763-2769.
17. Oved, K., Ziv, O., Jacob-Hirsch, J., Noy, R., Novak, H., Makler, O., Galit, D. et al., A novel postpriming regulatory check point of effector/memory T cells dictated through antigen density threshold-dependent anergy. J. Immunol. 2007. 178: 2307-2317.
18. Kario, E., Tirosh, B., Ploegh, H. L. and Navon, A., N-linked glycosylation does not impair proteasomal degradation but affects class I major histocompatibility complex presentation. J. Biol. Chem. 2008. 283: 244-254.
19. Reits, E., Griekspoor, A., Neijssen, J., Groothuis, T., Jalink, K., van Veelen, P., Janssen, H. et al., Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity 2003. 18: 97-108.
20. Kunisawa, J. and Shastri, N., The group II chaperonin TRiC protects proteolytic intermediates from degradation in the MHC class I antigen processing pathway. Mol. Cell. 2003. 12: 565-576.